威海廣泰(002111.SZ):擬以2.6億元收購廣大航服100%股權
格隆匯5月23日丨威海廣泰(002111.SZ)公佈,為完善公司產業鏈佈局,增強盈利能力,提升整體質量,充分發揮公司與廣大航服的協同效應,減少關聯交易,公司擬以現金2.6億元收購李文軒、威海廣大啟正企業管理中心(有限合夥)、李波、張東亮等16名股東持有的山東廣大航空地面服務股份有限公司(簡稱“廣大航服”)合計100%股權(簡稱“本次交易”)。
2022年5月23日,公司與李文軒、威海廣大啟正企業管理中心(有限合夥)、李波、張東亮等全部16名股東簽訂《威海廣泰空港設備股份有限公司收購廣大航服100%股權的股權轉讓協議》。本次交易完成後,廣大航服將成為威海廣泰的全資子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.